ArticleFrontiers in pharmacology2024

Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study.

Hongxin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.